Showing 161 - 180 results of 7,662 for search '(( mri also increased ) OR ((( c largest decrease ) OR ( ((c larger) OR (c large)) decrease ))))', query time: 0.53s Refine Results
  1. 161
  2. 162
  3. 163
  4. 164
  5. 165

    Table_3_Elevated gonadotropin levels are associated with increased biomarker risk of Alzheimer's disease in midlife women.DOCX by Matilde Nerattini (17437377)

    Published 2023
    “…</p>Methods<p>We examined 191 women ages 40–65 years, carrying risk factors for late-onset AD, including 45 premenopausal, 67 perimenopausal, and 79 postmenopausal participants with clinical, laboratory, cognitive exams, and volumetric MRI scans. Half of the cohort completed <sup>11</sup>C-Pittsburgh Compound B (PiB) amyloid-β (Aβ) PET scans. …”
  6. 166

    Table_5_Elevated gonadotropin levels are associated with increased biomarker risk of Alzheimer's disease in midlife women.DOCX by Matilde Nerattini (17437377)

    Published 2023
    “…</p>Methods<p>We examined 191 women ages 40–65 years, carrying risk factors for late-onset AD, including 45 premenopausal, 67 perimenopausal, and 79 postmenopausal participants with clinical, laboratory, cognitive exams, and volumetric MRI scans. Half of the cohort completed <sup>11</sup>C-Pittsburgh Compound B (PiB) amyloid-β (Aβ) PET scans. …”
  7. 167

    Table_7_Elevated gonadotropin levels are associated with increased biomarker risk of Alzheimer's disease in midlife women.DOCX by Matilde Nerattini (17437377)

    Published 2023
    “…</p>Methods<p>We examined 191 women ages 40–65 years, carrying risk factors for late-onset AD, including 45 premenopausal, 67 perimenopausal, and 79 postmenopausal participants with clinical, laboratory, cognitive exams, and volumetric MRI scans. Half of the cohort completed <sup>11</sup>C-Pittsburgh Compound B (PiB) amyloid-β (Aβ) PET scans. …”
  8. 168

    Table_2_Elevated gonadotropin levels are associated with increased biomarker risk of Alzheimer's disease in midlife women.DOCX by Matilde Nerattini (17437377)

    Published 2023
    “…</p>Methods<p>We examined 191 women ages 40–65 years, carrying risk factors for late-onset AD, including 45 premenopausal, 67 perimenopausal, and 79 postmenopausal participants with clinical, laboratory, cognitive exams, and volumetric MRI scans. Half of the cohort completed <sup>11</sup>C-Pittsburgh Compound B (PiB) amyloid-β (Aβ) PET scans. …”
  9. 169

    Table_4_Elevated gonadotropin levels are associated with increased biomarker risk of Alzheimer's disease in midlife women.DOCX by Matilde Nerattini (17437377)

    Published 2023
    “…</p>Methods<p>We examined 191 women ages 40–65 years, carrying risk factors for late-onset AD, including 45 premenopausal, 67 perimenopausal, and 79 postmenopausal participants with clinical, laboratory, cognitive exams, and volumetric MRI scans. Half of the cohort completed <sup>11</sup>C-Pittsburgh Compound B (PiB) amyloid-β (Aβ) PET scans. …”
  10. 170

    Table_6_Elevated gonadotropin levels are associated with increased biomarker risk of Alzheimer's disease in midlife women.DOCX by Matilde Nerattini (17437377)

    Published 2023
    “…</p>Methods<p>We examined 191 women ages 40–65 years, carrying risk factors for late-onset AD, including 45 premenopausal, 67 perimenopausal, and 79 postmenopausal participants with clinical, laboratory, cognitive exams, and volumetric MRI scans. Half of the cohort completed <sup>11</sup>C-Pittsburgh Compound B (PiB) amyloid-β (Aβ) PET scans. …”
  11. 171

    Table_1_Elevated gonadotropin levels are associated with increased biomarker risk of Alzheimer's disease in midlife women.DOCX by Matilde Nerattini (17437377)

    Published 2023
    “…</p>Methods<p>We examined 191 women ages 40–65 years, carrying risk factors for late-onset AD, including 45 premenopausal, 67 perimenopausal, and 79 postmenopausal participants with clinical, laboratory, cognitive exams, and volumetric MRI scans. Half of the cohort completed <sup>11</sup>C-Pittsburgh Compound B (PiB) amyloid-β (Aβ) PET scans. …”
  12. 172
  13. 173
  14. 174
  15. 175
  16. 176
  17. 177

    DataSheet_1_Pancreatic steatosis and iron overload increases cardiovascular risk in non-alcoholic fatty liver disease.docx by David Marti-Aguado (16739571)

    Published 2023
    “…MRI-biomarkers of fat fraction (PDFF) and iron accumulation (R2*) were obtained from the liver and pancreas. …”
  18. 178
  19. 179
  20. 180